Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Czechia / NCT07019727
Recruiting Not applicable

ESSKA/ESMA ACL Injury Prevention Program in Czech Sport

NCT07019727 · tracked via the Priya Life Science Czechia tracker
Sponsor
Masaryk University
Phase
Not applicable
Started
2025-06-12
Last updated
2025-09-30

Condition(s) studied

Double Leg Vertical Jump (DLVJ)Single Leg Squat (SLS)Single Leg Drop Landing (SLDL)Drop Jump Test (DJ Test)

Investigational drug(s) / intervention(s)

ESSKA/ESMA 'ACL Prevention for All' methodology

ESSKA/ESMA 'ACL Prevention for All' methodology: A workshop led by a trained physiotherapist/strength and conditioning coach and conducted under medical supervision. Based on the ESSKA/ESMA 'ACL Prevention for All' methodology, a total of 12 exercise units lasting 5 minutes each will be included.

Study summary

This study aims to address the rising incidence of ACL injuries, particularly among adolescents, by developing and implementing a comprehensive prevention program based on the evidence-based "ACL Prevention for ALL" framework recommended by ESSKA-ESMA. The project focuses on muscle strengthening, flexibility, coordination, proper movement techniques, and a multidisciplinary approach involving coaches, physiotherapists, and physicians. Through targeted exercise modules, education, and dynamic evaluation-including 2D motion analysis-the study seeks to reduce ACL injuries, enhance movement safety, and enable individualized training plans by identifying and correcting muscle and biomechanical imbalances.

Eligibility

Sex
ALL
Min age
17 Years
Max age
20 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age group: Participants aged 17-20 years Sports activity: Individuals actively engaged in sports with a high risk of ACL injury Health status: Participants with no or minimal previous knee joint injuries that do not limit their current physical activity Willingness to participate: Agreement to take part in the prevention program, including regular training and assessments Informed consent: Signed informed consent for participation in the program and testing procedures; for minors, consent must be signed by legal guardians Exclusion Criteria: Current injury: Individuals with a current knee joint injury requiring treatment or surgery Chronic conditions: Participants with chronic diseases or conditions that may affect the outcome of injury prevention (e.g., congenital abnormalities, neuromuscular disorders, or cardiovascular diseases) Insufficient consent: Individuals who are unable or unwilling to provide written informed consent Irregular participation: Individuals who do not comply with regular participation in the training program or assessments

Primary outcome measure(s)

  • Peak knee abduction moment — 4 months
    The strongest predictor of ACL injury risk according to the 'ligament dominance theory' and also the most frequently reported as changed after an IPP (Injury Prevention Program). Advantage: Quantifiable, measurable using 3D analysis and force platforms, and sensitive to changes.
  • Peak knee flexion angle — 4 months
    According to the 'quadriceps dominance theory,' a low angle increases the risk of ACL injury. Meta-analyses show an increase in the angle after IPP. Advantage: Easily measurable and consistently monitored in the literature.
  • Dynamic knee valgus (DKV) — 4 months
    Dynamic valgus is often described as a key injury mechanism, although its measurement is more complex and less standardized. It can be supplemented with specific angles such as knee abduction angle at initial contact (IC) and medial knee displacement.

Trial sites (1)

FacilityCityRegionStatus
Faculty of Medicine, Masaryk University Brno Czechia Recruiting

More Masaryk University trials in Czechia

Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia Active, not recruiting
Evaluation of Catching Skills in Preschoolers With Motor Difficulties Recruiting
Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy Recruiting
Early Detection of Familial Hypercholesterolaemia in Pre-school Children ( CzeCH-IT) Active, not recruiting
PRediction of Vagal Nerve Stimulation EfficaCy In Drug-reSistant Epilepsy Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07019727 on ClinicalTrials.gov ↗ ← All trials in Czechia